User:Mr. Ibrahem/Efavirenz/lamivudine/tenofovir

Efavirenz/lamivudine/tenofovir (EFV/3TC/TDF), sold under the brand name Telura, is a fixed-dose combination medication for the treatment of HIV/AIDS. It combines efavirenz, lamivudine, and tenofovir disoproxil. , it is listed by the World Health Organization as an alternative first line option to dolutegravir/lamivudine/tenofovir. It is taken by mouth.

Side effects can include joint pain, sleepiness, headaches, depression, trouble sleeping, and itchiness. Severe side effects may include depression, psychosis, or osteonecrosis. In those with a history of epilepsy, it may increase the frequency of seizures. Greater care should also be taken in those with kidney problems. It is unclear if use during pregnancy is safe.

It is on the World Health Organization's List of Essential Medicines. A year of medication is estimated to costs 154 USD in the developing world as of 2011. The combination received tentative approval in the United States in 2014. Its availability and importance is supported by Medecins Sans Frontieres.